3D PREDICT GLIOMA

Assays for clinical laboratory or research purposes, namely, for testing anti-cancer therapies, other than for medical or veterinary use; Assays for use in anti-cancer therapy research; Assays for testing cellular response to anti-cancer therapies, other than for medical or veterinary use; Assay kits comprising cell culture reagents and assays for culturing cells for clinical laboratory or research use

Assay kits comprising clinical medical reagents for culturing cells for clinical medical use

Scientific instruments and apparatus for ex vivo three-dimensional cell culture, namely, bioreactor for cell culturing, for laboratory use; scientific instruments and apparatus for ex vivo microtumor modeling

Medical apparatus, devices, and instruments for the analysis of tumor response to anti-cancer therapies; Kit comprising medical apparatus, devices, and instruments for performing clinical assays of anti-cancer therapies

Medical research services related to predictive tests for patient benefit from anti-cancer drugs or combination of drugs; Pharmaceutical research services, namely, preclinical assessment of pharmaceutical drugs; Scientific and technological services, namely, research in the field of anti-cancer therapies using ex vivo assays; Medical testing services, namely, performing nonclinical assays and testing for medical research purposes in the field of anti-cancer therapies, not for diagnostic or treatment purposes; Providing medical and scientific research information in the field of clinical trials, assays, and assay development, and cancer; Laboratory research in the field of oncology

Medical clinical testing services for diagnostic or treatment purposes, namely, conducting predictive patient-specific clinical assays, modeling and assessing response of live cancer cells to investigational and approved cancer therapies; Medical services in the nature of personalized medicine services, namely, conducting predictive patient-specific clinical assays, modeling and assessing response of live cancer cells to investigational and approved cancer therapies